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Suppression of chaperone-mediated autophagy in the renal cor-
tex during acute diabetes mellitus.
Background. In the renal hypertrophy that occurs in diabetes
mellitus, decreased proteolysis may lead to protein accumu-
lation, but it is unclear which proteins are affected. Because
the lysosomal proteolytic pathway of chaperone-mediated au-
tophagy is suppressed by growth factors in cultured cells, we
investigated whether the abundance of substrates of this path-
way increase in diabetic hypertrophy.
Methods. Rats with streptozotocin (STZ)-induced diabetes
were pair-fed with vehicle-injected control rats. Proteolysis was
measured as lysine release in renal cortical suspensions and pro-
tein synthesis as phenylalanine incorporation. Target proteins
of chaperone-mediated autophagy were measured in cortical
lysates and nuclear extracts by immunoblot analysis. Proteins
that regulate chaperone-mediated autophagy [the lysosomal-
associated membrane protein 2a (LAMP2a) or the heat shock
cognate protein of 73 kD (hsc-73)] were measured in lysosomes
isolated by density gradient centrifugation.
Results. Proteolysis decreased by 41% in diabetic rats; pro-
tein synthesis increased at 3 days, but returned to baseline by
7 days. The abundance of proteins containing that chaperone-
mediated autophagy KFERQ signal motif increased 38% and
individual KFERQ containing proteins [e.g., M2 pyruvate ki-
nase, glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and pax2] were more abundant. LAMP2a and hsc73 decreased
by 25% and 81%, respectively, in cortical lysosomes from dia-
betic vs. control rats.
Conclusion. The decline in proteolysis in acute diabetes
mellitus is associated with an increase in proteins degraded
by chaperone-mediated autophagy and a decrease in proteins
which regulate this pathway. This study provides the first evi-
dence that reduced chaperone-mediated autophagy contributes
to accumulation of specific proteins in diabetic-induced renal
hypertrophy.
Growth of the mature kidney (renal hypertrophy) oc-
curs in many disorders, but the mechanisms controlling
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this growth remain unclear. Protein accumulation during
growth results from an imbalance between the rates of
synthesis and degradation of intracellular protein. In con-
ditions such as diabetes or acidosis, growth of the kidney
occurs despite an overall increase in protein catabolism
and a decrease in tissue mass in other organs [1–4]. Be-
cause growth responses in the kidney are associated with
the development of chronic renal insufficiency, under-
standing the mechanisms underlying renal cell growth in
these metabolic conditions could lead to strategies for
therapeutic intervention.
Protein accumulation in growth has been traditionally
thought to result from increased protein synthesis. How-
ever, in some in cell culture models of renal hypertrophy,
protein degradation is suppressed and it appears that a
lysosomal proteolytic system is affected [2, 5, 6]. Because
growth in the diabetic kidney occurs under the influence
of growth factors [7], we examined changes in proteoly-
sis in cultured renal tubule cells in response to epidermal
growth factor (EGF). EGF treatment specifically sup-
pressed lysosomal proteolysis; EGF did not affect pro-
teasomal and calcium-sensitive proteolytic pathways [6].
Which lysosomal pathway might be regulated in
diabetes? Proteins can be degraded by lysosomes (1) via
macroautophagy of cytosol, membrane, or organelles
or (2) through direct import through the lysosomal
membrane [8, 9]. The best-described direct import
pathway is chaperone-mediated autophagy in which the
heat shock cognate protein of 73 kD (hsc-73) recognizes
a peptide sequence (consensus sequence Lys-Phe-Glu-
Arg-Gln or KFERQ) within the protein and unfolds the
target [10]. Hsc-73 also interacts with an intrinsic
lysosomal membrane protein, the lysosomal-associated
membrane protein 2a (LAMP2a), also called 96 kD lyso-
somal glycoprotein in rats. These interactions facilitate
the transfer of KFERQ-containing proteins into the lyso-
some where they are degraded [11]. In kidney, up to 30%
of cellular proteins contain a KFERQ motif [12], includ-
ing many proteins involved in growth regulation [2, 13].
In cultured renal epithelial cells, chaperone-mediated
autophagy is down-regulated during hyperplasia
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induced by EGF or hypertrophy induced by ammonia
[14]. These data suggest that chaperone-mediated
autophagy is down-regulated in conditions that are
associated with renal growth, in vivo.
In this report we investigated whether chaperone-
mediated autophagy is regulated in acute diabetes mel-
litus. In experimental rats, acute diabetes mellitus is
marked by hyperphagia. This notable because both to-
tal lysosomal proteolysis and chaperone-mediated au-
tophagy are extremely sensitive to dietary changes [8, 15–
17]. In particular, chaperone-mediated autophagy in the
kidney is markedly up-regulated during starvation and
suppressed by feeding [12]. This sensitivity to diet makes
it impossible to determine if changes in proteolysis are
due to differences in food consumption or due to signals
independent of protein and caloric intake unless the diet
is controlled. Therefore, we studied acutely diabetic rats
using a pair-feeding protocol to dissociate alterations in
proteolysis that are due to increased caloric and protein
intake from changes induced by diabetes. We provide ev-
idence that the reduction in proteolysis in the renal cor-
tex of rats with streptozotocin (STZ)-induced diabetes
is correlated with alterations in markers of chaperone-
mediated autophagy activity.
METHODS
Animal model
Male Sprague-Dawley rats weighing ∼200 g were given
STZ (in citrate buffer, 0.1 mol/L, pH 4.0; 65 or 125 mg/kg
body weight) or vehicle via a single tail vein injection at
7:00 a.m. as described [18]. They were placed in individual
metabolic cages and fed a 23% protein, powered chow ad
libitum. During the first 24 to 48 hours after injection the
diabetic rats ate less chow than their pair-fed controls, so
the quantity of food eaten by the STZ-treated rats was
measured and the control rats were pair-fed an equivalent
amount of chow. By the end of the second day, the dia-
betic rats became hyperphagic and the diabetic animals
were then fed only the amount of food eaten by the ad
libitum–fed control animals. The animals had unlimited
access to water. Glycosuria and ketonuria were measured
daily using Multistix (Miles, Elkhart, IN, USA). Rats were
studied at 3 or 7 days of hyperglycemia (4 or 8 days after
the STZ injection). At the time of sacrifice, blood was
obtained by aortic puncture for measurement of blood
glucose level with One Touch Profile (Life Scan, Milpi-
tas, CA, USA) and for arterial blood gas using OPTI 1
(AVL, Roswell, GA, USA). The protocol was approved
by the Emory University Institutional Animal Care and
Use Committee.
Chemicals
All chemicals or reagents were purchased from Sigma
Chemical Co. (St. Louis, MO, USA) except Dulbecco’s
modified Eagle’s media (DMEM) and MG132, which
were obtained from Gibco (Grand Island, NY, USA);
metrizamide was obtained from Accurate Chemical &
Scientific (Westbury, NY, USA); STZ was obtained from
ICN (Aurora, OH, USA) and L-[U-14C] phenylala-
nine was from Dupont (Boston, MA, USA); anti-M2
pyruvate kinase was from Scebo-Tech, A.G. (Giessen,
Germany); anti-hsc-73 antisera was from Maine Biotech-
nology (Portland, ME, USA); anti-glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was from
Biodesign International (Kennebunk, ME, USA); anti-
pax2 and 14–3-3f were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Affinity-purified antisera
to the pentapeptide KFERQ and to LAMP2a were a
generous gift from Dr. J.F. Dice, Tufts University, Boston,
Massachusetts.
Cortical suspensions
Kidney cortices from three rats were pooled together
and washed in a ultrafiltrate-like solution containing (in
mmol/L) 115 NaCl, 2.1 KCl, 25 NaHCO3, 1.2 MgCl2, 1.2
MgSO4, 1.2 CaCl2, and 2.4 KH2PO4 that was then equili-
brated with a gaseous mixture of 95% O2/5% CO2 at 4◦C.
Cortices were minced with a razor blade, then incubated
in the same solution with 0.1% collagenase, 0.25% albu-
min, 25 mmol/L mannitol, 5 mmol/L glucose, 4 mmol/L
sodium lactate, 1 mmol/L alanine, 1 mmol/L sodium bu-
tyrate under a 95% O2/5% CO2 atmosphere for 45 min-
utes in a shaker bath. Collagenase digestion was stopped
by dilution in cold ultrafiltrate-like solution and the sus-
pension was filtered through two layers of cotton gauze.
The viability of the cortical tubule cells was assessed by
trypan blue exclusion.
Measurement of protein synthesis and degradation
in renal cortical suspensions
The cortical suspension was washed and resuspended
in lysine-free, low glucose DMEM for measurement of
synthesis and degradation by the method of May et al [19].
Briefly, after a 30-minute preincubation, the suspension
was divided into aliquots containing 5 to 10 mg tubule
protein/flask, and incubated with L-[U-14C] phenylala-
nine to measure protein synthesis. Samples of the media
were removed at 20-minute intervals and protein was pre-
cipitated by adding trichloroacetic acid (TCA) to a final
concentration of 10%. After the last time point, precipi-
tated tubule protein was dissolved overnight at 37◦ C in
1 mL N NaOH for protein determination to normalize
results per gram of the protein.
Protein degradation was measured as the release of
TCA-soluble lysine into the media. Lysine was quantified
using high-performance liquid chromatography (HPLC)
after precolumn derivatization with 9-flourenylmethyl
chloroformate [19]. To examine the role of lysosomal
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pathways, kidneys from 6 animals of each group (control
and diabetes) were pooled and the resulting cortical sus-
pensions divided into two separate suspensions. One con-
trol and one diabetic suspension had 10 mmol/L NH4Cl
added to inhibit lysosomal proteolysis and then protein
degradation was measured on the suspensions as above.
Isolation of kidney lysosomes
Kidney lysosomes were isolated from a light
mitochondria-lysosomal fraction in a discontinuous
metrizamide density gradient as modified for kid-
ney cells by Cuervo et al [20]. Briefly, Spraque-
Dawley rats were anesthetized by intraperitoneal in-
jection with phenobarbital solution (0.5 mg/kg) (Ab-
bott, Abbott Park, IL, USA). Kidney cortices from
two or three rats were pooled, minced, and homog-
enized with a Teflon homogenizer. The homogenate
was filtered through double layers of gauze by
adding chilled 0.25 mol/L sucrose (4 mL/g of kidney
cortex) and centrifuged at 6800g for 15 minutes. The su-
pernatant was centrifuged at 17,000g for 20 minutes. The
pellet (mitochondrial-lysosomal fraction) was washed
once in 0.25 mol/L sucrose and resuspended in 57%
metrizamide (final concentration) and a discontinuous
gradient of metrizamide was constructed (layers from the
bottom to top were 57%, 32.8%, 26.3%, and 19.8%) then
centrifuged 1 hour at 17000g. Isolated lysosomes were
collected from the top layer and the 26.3%/19.8% inter-
face. In all experiments, purity of the lysosomal fraction
was determined by measuring b-N-hexosaminidase ac-
tivity as described [21]. When the b-N-hexosaminidase
activity in the lysosomal preparations from diabetic and
pair-fed control rats was not equal, the preparations were
not included in the analysis. Mitochondrial contamina-
tion was assayed by phase contrast microscopy and was
not detected in any lysosomal fraction.
Western blotting
Aliquots of the lysosomal fraction or homogenized
lysates were mixed with sample buffer containing 1%
sodium dodecyl sulfate (SDS), 0.5% b-mercaptoethanol,
and boiled for 5 minutes. Proteins were separated by SDS-
polyacrylamide gel electrophoresis (PAGE) and trans-
ferred to nitrocellulose membranes. Membranes were
stained with Ponceau S Red to visualize the complete-
ness of the protein transfer and consistency of lane load-
ing. Membranes were blocked with either 5% powdered
milk or 3% bovine serum albumin (BSA) solution added
to Tris-buffered saline (TBS) containing 0.1% Tween-
20. Primary antibodies (see Materials section) were de-
tected using the enhanced chemiluminescence (ECL)
system (Amersham, Buckinghamshire, UK) and using
Kodak BCL film.
Nuclear extract preparation and electrophoretic mobility
shift assay (EMSA)
Nuclear protein extracts were prepared from renal cor-
tex by the method of Dignam [22]. Protein:DNA binding
assays were performed as described [23]. Briefly, nuclear
protein extracts (1 lg) were preincubated for 5 minutes
on ice in a reaction buffer containing 15 mmol/L HEPES
(pH 7.9), 50 mmol/L KCl, 5 mmol/L MgCl2, 0.12 mmol/L
ethylenediaminetetraacetic acid (EDTA), 10% glycerol,
0.25 mg/mL bovine serum albumin (BSA), 0.05%
Nonidet P-40, 10 mmol/L dithiothreitol (DTT), and 200
ng of poly (dI/dC). In some instances, a double-stranded
competitor probe (0.7 pmol) or an anti-pax2 or GAPDH
antibody (2 lg) (Santa Cruz Biotechnology or Biodesign,
respectively) was included in the preincubation mixture.
Competitor probes were created by annealing comple-
mentary 40 base oligonucleotides. A [c-32P] adenosine
triphosphate (ATP) 5′-end-labeled (5 ×105 dpm), gel-
purified, double-stranded probe corresponding to the
pax2 binding site in the murine thyroglobulin promoter
was added to each binding reaction (20 lL total volume),
and the mixtures were incubated on ice for an additional
25 minutes before electrophoretic separation in a 5%
nondenaturing acrylamide gel. The sequence of the sense
strand of the probe was 5′-TTCGTGGTCATGTAAG
TTGTTTCACTTGGATGAAATCCCTCTTCAGGA
GATGTT. This site does bind pax5 and pax8 as well
as pax2. This DNA probe was labeled with Klenow
enzyme before a binding reaction with nuclear extracts.
Antibody blocking was performed by preincubating the
nuclear extracts for 30 minutes at room temperature
(RT) with pax2 or GAPDH (Biodesign) antibodies.
Statistics
Results are expressed as mean ± SEM. Differences
between two groups were analyzed by paired t test, and
multiple comparisons were analyzed by analysis of vari-
ance (ANOVA) and were considered significant when P
< 0.05.
RESULTS
Food intake over the course of the experiment did not
differ between rats that were injected with 125 mg/kg
of STZ and their pair-fed, vehicle-injected control rats
(Table 1). After 3 or 7 days of hyperglycemia, kidney
weight expressed per gram of body weight was increased
in diabetes rats compared to values in controls. Urine
samples were positive for ketones in most diabetic rats at
day 2, but were negative in most by day 3 and in all by
day 4. Plasma bicarbonate values (measured in a subset
of eight control and diabetic rats) were not different be-
tween diabetic and control rats after 7 days. To evaluate
renal protein turnover in diabetes, we measured the rates
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Table 1. Results of pair-feeding of Sprague-Dawley rats made diabetic with streptozotocin (STZ) at the indicated dose and pair-fed for the
indicated time as described in the Methods section
Day 3 125 mg/kg Body weight Body weight Blood glucose Kidney weight/
(N = 6) day 0 g day 3 g Chow/day g mg/dL Kidney weight g 100 g body weight
Control 202 ± 3 220 ± 4 19 ± 1 122 ± 13 1.94 ± 0.03 0.88 ± 0.02
Diabetes 196 ± 2 206 ± 3a 20 ± 1 350 ± 27a 2.24 ± 0.1b 1.08 ± 0.05a
Day 7 125 mg/kg Body weight Body weight Chow/day g Blood glucose Kidney weight g Kidney weight/
(N = 18) day 0 g day 7 g mg/dL 100 g body weight
Control 203 ± 26 265 ± 29 25 ± 3 128 ± 11 2.31 ± 0.25 0.88 ± 0.09
Diabetes 199 ± 28 175 ± 18a 26 ± 4 391 ± 107a 2.33 ± 0.23 1.34 ± 0.12a
Day 7 65 mg/kg Body weight Body weight Chow/day g Blood glucose Kidney weight g Kidney weight/
(N = 18) day 0 g day 7 g mg/dL 100 g body weight
Control 241 ± 2 292 ± 4 29 ± 1 109 ± 10 2.42 ± 0.09 0.83 ± 0.03
Diabetes 240 ± 3 231 ± 7a 29 ± 1 159 ± 23c 2.39 ± 0.19 1.33 ± 0.14a
aP < 0.01; bP < 0.05; cP = 0.06.
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Fig. 1. Acute diabetes suppresses protein
degradation in renal cortical suspensions.
Sprague-Dawley rats were given a single in-
travenous injection of 125 mg/kg streptozo-
tocin (DM) and then pair-fed with vehicle-
injected control (Con) rats for 3 (A) or 7 days
(B). The rate of protein degradation was mea-
sured as lysine release on cortical suspensions
(see Methods section). Results for individual
pair-fed animals are indicated by a line. P <
0.05 for both time points, N = 6 at 3 days,
N = 5 at 7 days. (C) Six DM rats and their pair-
fed controls were treated for 7 days and had
their kidneys pooled for cortical suspensions.
The suspensions were divided and 10 mmol/L
NH4Cl was added during the protein degra-
dation measurement to one-half the sample.
The results shown are those of a representa-
tive experiment of two repeats.
of protein degradation and synthesis in renal cortical sus-
pensions from six diabetic and pair-fed controls. Protein
degradation in the cortical suspensions from diabetic rats
was decreased by 40% ± 10% at 3 days (N = 6, P < 0.05)
and 41% ± 15.4% after 7 days of hyperglycemia (N =
5, P < 0.05) compared to controls (Fig. 1). In the same
preparations, protein synthesis was increased by 46% ±
4% (P < 0.05, N = 3) in suspensions from diabetic rats
compared to control at 3 days, but was not significantly in-
creased at 7 days (a decrease of 8.5% ± 11%, NS, N = 5).
To determine the proteolytic pathway that is regulated,
we used 10 mmol/L NH4Cl to inhibit lysosomal proteoly-
sis. NH4Cl reduced proteolysis in suspensions from both
control and diabetic rats. Significantly, NH4Cl markedly
decreased the difference between control and diabetic
proteolytic rates (Fig. 1C) suggesting that diabetes pre-
dominantly suppresses a lysosomal pathway.
Next, we examined whether substrates of chaperone-
dependent autophagy (i.e., KFERQ-containing proteins)
accumulate in renal cortical cells in response to diabetes.
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Fig. 2. Acute diabetes increases renal cortical KFERQ protein abundance. Rats were treated with 125 mg/kg streptozotocin (STZ) as in figure 1
(DM) and pair-fed with control rats (C) for 7 days. (A) Western blot analysis was performed with whole cell homogenates of renal cortex (40 lg
protein/lane) and probed with primary antibodies to the M2 isoform of pyruvate kinase (M2PK), heat shock cognate protein of 73 kD (hsc-73),
or a polyclonal antisera to the KFERQ peptide motif. The images shown are representative blots from eight pairs of diabetic and control rats. (B)
Western blot analysis was performed with whole cell homogenates of renal cortex (40 lg protein/lane) and isolated lysosomes (6 lg protein/lane) and
probed with primary antibodies to glyceraldhyde-3-phosphate dehyrodrogenase (GAPDH) (a representative blot of three repeats). (C) Western
blot analysis was performed with whole cell homogenates of renal cortex (40 lg protein/lane) and probed with primary antibodies against 14-3-3f ,
and a-actin (a representative blot of four repeats). (D) Densitometry results of blots described in (A to C) plotted as change from control amount.
∗P < 0.01 vs. control by paired t test (N = 4 to 8).
The abundance of proteins recognized by affinity-purified
antibodies against the pentapeptide KFERQ motif was
not significantly changed at 3 days after STZ injection
(10% ± 9% increase in diabetics, N = 5), but the abun-
dance of these proteins increased 38% ± 8% in 7 days
diabetics vs. controls (P < 0.05, N = 5) (Fig. 2). We also
examined the M2 isoform of pyruvate kinase (M2PK), a
protein that contains the KFERQ motif, and it was in-
creased by 239% ± 209% in diabetic rats at 3 days (N =
6, NS) and by 356% ± 98% (N = 6, P < 0.05) at 7 days
(Fig. 2). GAPDH is a known substrate of chaperone-
mediated autophagy [21] that is typically not regulated by
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Fig. 3. Acute diabetes increases pax2 protein abundance and DNA
binding. Rats were treated with 125 mg/kg streptozotocin (STZ) as in
figure 1 (DM) and pair-fed with control rats (Con) for 7 days. (A) West-
ern blot analysis was performed with whole cell homogenates of renal
cortex (40 lg protein/lane), isolated lysosomes (6 lg protein/lane), or
nuclear extracts (10 lg protein/lane) and probed with primary anti-
bodies to pax2. The images shown are representative blots from four
separate experiments. (B) Electrophoretic mobility shift assays were
performed as described in the Methods section. Cold probe, pax2 anti-
bodies, or glyceraldhyde-3-phosphate dehyrodrogenase (GAPDH) an-
tibodies were incubated with the nuclear extract for 30 minutes prior to
addition of the labeled probe. Image shown is a representative autora-
diogram from four separate experiments.
transcriptional mechanisms. Its abundance was increased
by 37% + 6% in cell homogenates from 7 day diabetic
rats (Fig. 2B). Consistent with decreased lysosomal im-
port, the amount of GAPDH found in lysosomes did not
change.
We have suggested that chaperone-mediated au-
tophagy may regulate growth processes by affecting the
degradation of specific transcription factors [2]. To test
this possibility, we examined KFERQ-containing pax2
Table 2. Typical results of hexosaminadase activity in isolated
lysosomes from the pooled renal cortices of two rats made diabetic
with 125 mg/kg streptozotocin (STZ) and their pair-fed controls after
7 days of diabetes; recovery of total protein and hexosaminadase
activity were measured, with no significant differences between
control and diabetes by paired t test
Hexosaminadase Specific
Control (N = 4) activity % Protein % activity
Homogenate 100 100 1
Lysosomes 3.05 ± 0.84 0.65 ± 0.25 5.66 ± 0.93
Diabetes (N = 4)
Homogenate 100 100 1
Lysosomes 2.95 ± 0.93 0.59 ± 0.23 5.78 ± 0.82
transcription factor, because it regulates the expression
of genes involved in renal growth and development [2].
Pax2 protein was undetectable in control cortex but was
detectable from lysosomes and nuclear extracts from con-
trol rats (Fig. 3). With diabetes (7 days), pax2 was faintly
detected in whole cortex, and was abundant in nuclear
extracts. Pax8 was also more abundant in nuclear ex-
tracts from diabetic renal cortices (data not shown). To
confirm the identity of pax2 in nuclear extracts, we ex-
amined its binding to the pax2 consensus site in the thy-
roglobulin promoter (Fig. 3). We observed enhanced pax2
binding in the nuclear extracts from the diabetic re-
nal cortex. The binding was diminished by preincuba-
tion with pax2-specific antibodies, but not by preincuba-
tion with nonspecific GAPDH antibodies. We also evalu-
ated the abundance of several other proteins lacking the
KFERQ sequence, including 14-3-3f and a-actin (Fig.
2C). Diabetes (7 days) did not change their abundance
in the renal cortex. These results are consistent with di-
abetes suppressing proteolysis via chaperone-mediated
autophagy.
We also measured levels of LAMP2a and hsc-73 be-
cause their lysosomal levels correlate with the activity
of chaperone-mediated autophagy [24]. No significant
change in LAMP2a or hsc-73 levels was detected by West-
ern blotting in whole cell lysates. This finding was not sur-
prising because these proteins only control the activity of
chaperone-mediated autophagy when they are associated
with the lysosome [24]. We isolated lysosomes from the
pooled renal cortex of two or three day 7 rats using a pro-
tocol modified for kidney tissue [20] and measured the
lysosomal distribution of hsc-73 and LAMP2a. The yield
and purity of lysosomes from kidney cortex from diabetic
and pair-fed control rats was equal as judged by protein
content and enrichment of the specific activity of the lyso-
somal enzyme, hexosaminadase (Table 2). LAMP2a was
enriched in the lysosomes approximately sixfold over the
levels in the unfractionated cell, but was not enriched
in renal cortical mitochondria (Fig. 4). In the lysosomes
isolated from the diabetic renal cortex, the amount of
LAMP2a and hsc-73 was 25% ± 12% and 81% ± 8%
(both P < 0.01, N = 4) lower than in the renal cortex of
control rats (Fig. 5).
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Fig. 4. Lysosomal-associated membrane protein 2a (LAMP2a) abun-
dance in renal cortical cell fractions. Lysosomes and mitochondria were
isolated from the renal cortices of two control rats (see Methods section)
and LAMP2a was detected by Western blot analysis. The experiment
was repeated three times with identical results. (A) Five micrograms
of isolated mitochondrial (Mito) and lysosomal (Lyso) fractions. (B)
Thirty micrograms of unfractionated cortical lysate protein (Lysate)
and 6 lg of lysosomal protein (Lyso).
To determine if LAMP2a and hsc-73 respond to a
less severe degree of diabetes, we examined the renal
cortices of rats given a lower dose of STZ. We ini-
tially attempted to use insulin treatment (1 to 2 units
of ultralente subcutaneously daily) for this purpose, but
insulin treatment reduced the purity of the isolated
lysosomes as measured by hexosamindase activity and
microscopy (Sooparb and Franch, unpublished data)
making the comparison difficult to interpret. Rats given
65 mg/kg STZ developed hyperglycemia, but urine ke-
tones were negative at all time points. Diabetic rats had
an increase in kidney weight/body weight 7 days after
STZ injection (Table 1). The amount of renal cortical
M2PK increased 308% ± 154% (P < 0.01, N = 6) in
diabetes. Once again, there was no difference in the pu-
rity of lysosomes isolated between control and diabetic
conditions as judged by protein content and enrichment
of the specific activity of hexosaminadase. LAMP2a and
hsc-73 levels in lysosomes isolated from the renal cortex
of diabetic rats were decreased by 16% ± 7% (NS) and
57% ± 20% (P < 0.05), respectively (N = 4), (Fig. 6) com-
pared to lysosomes isolated from cortices of their pair-fed
controls.
DISCUSSION
Previous studies have suggested that renal hypertro-
phy is associated with decreased protein breakdown. In
1968, Coe and Korty [25] noted that uninephrectomy
suppressed L-[14C] leucine release from prelabeled cor-
tical slices. Shecter, Boner, and Rabkin [26] and Fawcett
et al [27] similar conclusions about the rate of protein
degradation in isolated proximal tubules from rats with
diabetes or metabolic acidosis. The accuracy of these
methods has been questioned because branched chain
amino acid (BCAA) tracers were used. BCAA are de-
graded by branched chain ketoacid dehydrogenase [28,
29], and the activity of this enzyme varies in the kidney un-
der different conditions including diabetes mellitus [30,
31]. Hence, differences in the specific radioactivity of the
intracellular pool of BCAA could be different in proxi-
mal tubule cells from control and diabetes rats. To avoid
this complication, we used lysine appearance to measure
protein degradation and synthesis because lysine is not
metabolized by the kidney [19].
A second notable difference between our experimental
model and those used in published reports is that we stud-
ied pair-fed diabetic and control rats to be certain that dif-
ferences in food intake did not confound our results. This
is important because diabetic rats consume considerably
more chow than controls. Several proteolytic pathways,
including lysosomal proteolysis via chaperone-mediated
autophagy, are affected by protein and caloric intake [15–
17, 24]. Our pair-feeding regimen resulted in a net re-
striction of dietary intake in the diabetic rats to avoid
the hyperphagia they develop in response to diabetes.
This is important because their higher food consumption
could have been the basis for the reduction in proteoly-
sis reported by others. The fact that lysosomal proteoly-
sis was reduced in our pair-fed diabetic rats proves that
the changes in cortical proteolysis results from pathologic
rather than nutritional signals. In contrast to the acceler-
ated protein degradation in muscle [18], acute diabetes
decreases protein degradation in the renal cortex, and this
response persists for at least 7 days even though protein
synthesis falls to the level measured in control rats within
this time frame. Thus, the kidney’s capacity to lower its
rate of proteolysis contributes to differential growth of
the kidney under these intensely catabolic conditions.
An initial clue that decreased lysosomal protein
degradation contributes to hypertrophy was the ob-
servation that growth stimuli (e.g., EGF or ammonia)
suppressed lysosomal proteolysis, but without changing
either ubiquitin-proteasome or calcium-activated prote-
olysis in cultured renal tubular cells [6]. Since our cell
culture experiments suggested that chaperone-mediated
autophagy may be involved in cell growth, we examined
whether this specific pathway is regulated in the kidney
by diabetes. We found that diabetes specifically decreases
lysosomal proteolysis (Fig. 1C) and leads to a decrease in
the amount of LAMP2a and hsc-73 associated with lyso-
somes in the renal cortex (Fig. 5). Since the amount of
LAMP2a in lysosomes directly correlates with the ac-
tivity of chaperone-mediated autophagy [24], it is likely
that the decrease in protein degradation we measured in
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Fig. 5. Diabetes suppresses heat shock cog-
nate protein of 73 kD (hsc-73) and lysosomal-
associated membrane protein 2a (LAMP2a)
in renal cortical lysosomes. Rats were treated
with 125 mg/kg streptozotocin (STZ) as in
figure 1 (D) and pair-fed with control rats
(C) for 7 days. Lysosomes were isolated from
the pooled cortices of two rats. (A) West-
ern blotting was performed with 6 lg of lyso-
somal protein and antibodies against hsc-73
or LAMP2a. Results of two representative
experiments out of six total is shown. (B)
Densitometry of LAMP2a and hsc-73 results
plotted as change from control amount. ∗P <
0.01 vs. control by paired t test.
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Fig. 6. Diabetes suppresses heat shock cog-
nate protein of 73 kD (hsc-73) and lysosomal-
associated membrane protein 2a (LAMP2a)
in renal cortical lysosomes from nonketotic
rats. Rats were treated as per figure 1 with
65 mg/kg streptozotocin (STZ) (D) and pair-
fed with control rats (C) for 7 days and lyso-
somes were isolated from the pooled cor-
tices of three rats. Results of a representative
experiment out of four total is shown. (A)
Western blot analysis performed with 6 lg
of lysosomal protein and antibodies against
hsc-73 or LAMP2a. (B) Densitometry of
LAMP2a and hsc-73 results plotted as change
from control amount. ∗P < 0.05 vs. control by
paired t test. (C) Western blot analysis (40 lg
of unfractionated cortical homogenate) was
performed with antibodies against the M2 iso-
form of pyruvate kinase.∗P < 0.05 vs. control
by paired t test.
cortical suspensions in diabetes is due in part to a reduc-
tion in chaperone-mediated autophagy. Consistent with
this conclusion, the amount of KFERQ-containing pro-
teins increases in the renal cortex of diabetic rats. Al-
though stimuli that increase lysosomal LAMP2a levels
have been described [24], this is the first report to docu-
ment suppression of basal levels of chaperone-mediated
proteolysis in vivo.
Lysosomal hsc-73 fell to a much greater extent than
LAMP2a. This finding is consistent with our previous ob-
servation that the magnitude of the change in lysosomal
hsc-73 correlates closely with changes in the half-life of
KFERQ containing proteins in cell culture [14]. Hsc-73
becomes associated with lysosomes during chaperone-
mediated autophagy and its abundance in lysosomes is a
sensitive marker for the activity of chaperone-mediated
autophagy [24, 32]. The decline in lysosomal LAMP2a
was much smaller in vivo than we observed in the cell
culture. This may reflect heterogeneity in the response
of different cell types or a smaller overall response than
in the cultured cells. Nevertheless, a 25% reduction in
the activity of chaperone-mediated autophagy results in
significant accumulation of KFERQ-containing proteins
(Fig. 2).
What is the signal that leads to suppression of
chaperone-mediated autophagy in diabetes? We can ex-
clude the potential role of protein or calorie intake in me-
diating the decrease in proteolysis due to diabetes based
on our pair-feeding. Ketosis could possibly result in an
acidosis that leads to increased ammoniagenesis in the re-
nal cortex [33], since we have shown that elevated levels
of ammonia are sufficient to increase KFERQ contain-
ing proteins and decrease lysosomal LAMP2a in cultured
renal cells [14]. However, the rats were only ketotic for
the first 3 of the 7-day period, had normal blood pH at
7 days, and rats given a nonketotic dose of STZ
still have decreased lysosomal hsc-73 in the renal cor-
tex (Fig. 6). Preliminary experiments with NH4Cl-fed
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animals showed that KFERQ containing proteins in-
crease significantly in only in frankly acidotic animals
(Sooparb and Franch unpublished data) suggesting that
subtle acid loading does not significantly influence this
pathway. Based on our findings in cultured renal tubular
cells [14], a more likely mechanism is that the increase in
growth factors, including EGF, in diabetic kidney drives
the suppression of chaperone-mediated autophagy [7,
34].
Our findings do not rule out the possibility that diabetes
induces the suppression of other lysosomal pathways, be-
cause conditions that accelerate chaperone-mediated au-
tophagy (e.g., starvation) also enhance macroautophagy
in mammalian cells [35]. They are also consistent with
a report that the activity of several lysosomal proteases,
(e.g., cathepsin D and L) are decreased in cortical sus-
pensions from diabetic animals [26]. However, it is not
been clear to what extent the in vitro cathepsin assay
reflects lysosomal proteolysis because (1) the activities
of cathepsins are measured at a suboptimal neutral pH
when the lysosomal pH in vivo is acidic and may be regu-
lated [9]; and (2) total lysosomal proteolysis is dependent
on translocation of proteins into the lysosome, [8, 36]. In
light of our present results, this report now can be seen to
suggest a general decrease in multiple lysosomal signaling
pathways.
It is unlikely that suppression of proteolysis is the sole
mechanism causing protein accumulation. Protein syn-
thesis was increased at 3 days and synthesis of specific
KFERQ proteins may have been increased because we
found large variations in the amounts of the KFERQ-
containing proteins that accumulate in the kidney of di-
abetic rats relative to controls (Fig. 2). We speculate that
suppression of proteolysis plays a crucial role in ampli-
fying changes in the production of certain proteins and
maintaining high levels of these long-lived proteins after
normalization of protein synthesis [14]. Prolonging the
half-life of transcription factors (such as pax2) may lead to
increased transcription and synthesis of specific proteins,
even though global protein synthesis is unchanged. Since
prolonging protein half-life reduces the energy demands
required for growth, a reduction in degradation may be
advantageous in conditions like diabetes that cause a neg-
ative nitrogen (protein) balance [18].
A limitation of our study is the inability to study pu-
rified lysosomes from diabetic rats given replacement
doses of insulin due to changes in lysosomal density.
Since insulin is used to treat most cases of severe human
diabetes, we must consider how insulin treatment might
influence the clinical relevance of our findings. Although
their methodology differs from our model, the work of
Shechter, Boner, and Rabkin [26] suggests that insulin
treatment partially reverses the effect of diabetes on pro-
teolysis. This report suggests that our results may be ap-
plicable to insulin-treated humans. However, it is possible
that there are significant differences as well. Certainly, we
found major alterations in lysosomal density with insulin
treatment, so further exploration of the effect of insulin
of the lysosomal system in the kidney is required. It is also
possible that protein synthesis makes a greater contribu-
tion in the growth of the kidney during insulin-treated,
human diabetes than we observed in our rat model.
Proteins with the KFERQ motif play crucial roles
in processes that are important for renal cell growth.
For example, renal growth is accompanied by an in-
crease in glycolysis [37] and a search of the Entrez pro-
tein database (www.ncbi.nlm.nih.gov/entrez) reveals that
many glycolytic enzymes contain KFERQ sequences,
including phosphofructokinase, glyceraldehyde 6 phos-
phate dehydrogenase, and pyruvate kinase. This is also
true for the Kennedy pathway of phospholipid synthesis
which includes choline kinase and phosphatidylcholine
transferase, two substrates of chaperone-mediated au-
tophagy. Some signaling proteins linked to growth (e.g.,
MARCKS protein, c-fos, and pax2) also contain KFERQ
motifs and we have shown that the half-life of the paired
box related transcription factor pax2 is increased by
growth factors in cultured renal tubular cells [14]. The
abundance of this developmentally important oncogene
is also increased in the cortex of rats with STZ-induced
diabetes (Fig. 3). Thus, chronic suppression of chaperone-
mediated autophagy is a mechanism that can augment
and maintain high levels of proteins required for renal
growth.
CONCLUSION
Our findings demonstrate that an intrinsic decline in
the activity of chaperone-mediated autophagy plays a
role in the renal hypertrophy associated with acute di-
abetes mellitus.
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